Viewing Study NCT04874194


Ignite Creation Date: 2025-12-25 @ 1:37 AM
Ignite Modification Date: 2025-12-28 @ 12:13 AM
Study NCT ID: NCT04874194
Status: TERMINATED
Last Update Posted: 2025-11-03
First Post: 2021-05-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Omacetaxine and Venetoclax for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Harboring Mutant RUNX1
Sponsor: M.D. Anderson Cancer Center
Organization: